Allergan, Shire Spar Over Pfizer-J&J Antitrust Ruling
Allergan and Shire are trading blows over a recent ruling that kept alive Pfizer's antitrust suit against Johnson & Johnson over alleged coercion of health insurers, debating whether it lends credence...To view the full article, register now.
Already a subscriber? Click here to view full article